iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

iHIVARNA Consortium

Research output: Contribution to journal › A1: Web of Science-article › peer-review

22 Downloads (Pure)

Fingerprint

Dive into the research topics of 'iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences